Liver Cancer 2.0
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242417275 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Hiroaki Taniguchi. Beteiligte Einrichtung: Department of Experimental Embryology, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, 05-552 Jastrzebiec, Poland. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Liver cancer, specifically hepatocellular carcinoma (HCC), is a major global health concern due to its high prevalence in many countries [...]
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Experimental Embryology, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, 05-552 Jastrzebiec, Poland.
Zitieren
APA
Taniguchi, H. (2023). Liver Cancer 2.0. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417275
Vancouver
Taniguchi H. Liver Cancer 2.0. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417275
BibTeX
@article{Taniguchi2023,
author = {Taniguchi, Hiroaki},
title = {Liver Cancer 2.0},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242417275}
}
EUVIMED